Home  - Science - Gene Therapy

Books Baby Camera Phones Computers Games DVD Electronics Kitchen Magazines Music Garden Software Tools Toys Video Apparel & Accessories Jewelry & Watches Musical Instruments Health & Personal Care Beauty Sports & Outdoors Office Products

e99.com Bookstore

Images

Newsgroups

81-88 of 88    Back | 1  | 2  | 3  | 4  | 5

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Gene Therapy:     more books (100)

Beaudet: Gene Transfer & Gene Therapy by AL BEAUDET, 1989-11-01 Great Medical Discoveries - Gene Therapy (Great Medical Discoveries) by Lisa Yount, 2002-01-15 Gene Therapy Musculoskeletal Disorders Gene Therapy: Treating Disease by Repairing Genes (The New Biology) New type of gene therapy temporarily cured diabetes in mice.: An article from: Transplant News Gene therapy in mice effective but caused serious side effects, study finds.(Brief Article): An article from: Transplant News Dermatology will be key to gene therapy success. (Expert Predictions).: An article from: Skin & Allergy News by Timothy F. Kirn, 2002-01-01 Stem Cells from Cord Blood, in Utero Stem Cells Development and Transplantation Inclusive Gene Therapy Gene Therapy: Application of Molecular Biology by James W. Larrick, Kathy L. Burck, 1992-09-14 Recent Development in Gene Therapy 2007 by Edited by Jim Xiang, 2007-06-01 Gene Therapy (Ernst Schering Research Foundation Workshop) by R.E., Ed. Sobol, 1998 US researchers on hot seat again after patient in gene therapy trial dies, may have worsened another's cancer.: An article from: Transplant News Science on the Edge - Gene Therapy (Science on the Edge) by Linda George, 2003-07-02 New Vistas in Therapeutics/Drug-Resistant Tuberculosis: From Drug Design to Gene Therapy : From Molecules to Macro-Economics (Annals of the New York Academy of Sciences)

lists with details

81. Tokyo Medical University Genetics Gene Therapy Problems
    Animations of Problems in gene therapy one gene is mutated and the other is inserted and mutated (7K). genes that are mutated don t work but the  
    http://www.tokyo-med.ac.jp/genet/gpr-e.htm

82. ACS :: Gene Therapy: Questions & Answers
    gene therapy Questions Answers. Introduction What Is a Gene? What Is gene therapy? How Does gene therapy Work? When Will gene therapy Be Available?  
    http://www.cancer.org/docroot/ETO/content/ETO_1_3X_Gene_Therapy_Questions_and_An
    
    Extractions: Making Treatment Decisions ... I Want to Help Help in the fight against cancer. Donate and volunteer. It's easy and fun! Learn more Introduction What Is a Gene? What Is Gene Therapy? ... Email this Page Also in this area Antiangiogenesis Treatment Welcome message Photodynamic Therapy Cord Blood Transplantation ... Building a Support Network createContextNavLink('', '/asp/login/logreg.asp?navToScreen=reg_0', '', '/docroot/ETO/content/ETO_1_3X_Gene_Therapy_Questions_and_Answers.asp', '', ''); Not registered yet? Register now or see reasons to register Help About ACS ACS Gift Shop ... Press Room

83. Salon.com Health | Gene Therapy R.I.P.?
    When the country s biggest gene therapy institute was ordered to stop testing on humans last week, the action marked the end of an era fraught with dubious  
    http://archive.salon.com/health/feature/2000/06/01/gene_therapy/index.html
    
    Extractions: By Tabitha M. Powledge In September, Jesse Gelsinger, a teenage patient undergoing experimental gene therapy for a rare genetic disorder, died at the Institute for Human Gene Therapy at the University of Pennsylvania. People die during experimental treatments all the time because they are usually terribly sick. But Jesse was not particularly ill, and his father says the researchers played up the potential benefits of the study and played down the potential risks. The researchers deny this, so Jesse's father is talking about filing suit.

84. Gene Therapy Study Likely To Resume - International Herald Tribune
    NEW YORK U.S. regulators have given permission for a company to resume a gene therapy study in which a woman died, the company was expected to announce  
    http://www.iht.com/articles/2007/11/26/america/gene.php
    
    Extractions: Search By Andrew Pollack Published: November 26, 2007 document.writeln(''); E-Mail Article Listen to Article Printer-Friendly 3-Column Format Translate Share Article Text Size NEW YORK U.S. regulators have given permission for a company to resume a gene therapy study in which a woman died, the company was expected to announce Monday. The death had threatened to be another black eye for gene therapy, a field that has not had much success in treating disease and that suffered a setback in 1999 when a teenager died while participating in a clinical trial at the University of Pennsylvania. A spokeswoman for the Food and Drug Administration said it could not comment on its communications with companies involving drugs in clinical trials. The agency halted the trial in July after the death of the woman, Jolee Mohr, 36, of Taylorville, Illinois. U.S. candidates get set for 2 crucial primaries Brazil announces new measures to fight Amazon deforestation Author of interrogation memos renominated for top post Mohr died three weeks after receiving her second injection of a gene meant to reduce inflammation and treat her rheumatoid arthritis. The direct cause of her death appeared to be a fungal infection, histoplasmosis, according to testimony at a review of her case in September by an advisory committee to the National Institutes of Health. But the committee said it was too early to conclude that the gene therapy had not been a factor.

85. Gene Therapy To Repair Injured Tendon-Health/Science-The Times Of
    LONDON A research team from University of Rochester Medical Centre is developing freezedried implants loaded with gene therapy solution that can help  
    http://timesofindia.indiatimes.com/HealthScience/Gene_therapy_to_repair_injured_
    
    Extractions: Tendons are elastic cords that anchor muscle to bone and enable flexing muscle to move limbs. In many standard repair attempts, surgeons implant an autograft, a piece of tendon from elsewhere in the same patient. Along with requiring patients to sacrifice tendon, the problem with 'live' autografts is that both the graft and the graft site 'know' they have been injured. That signals immune cells and chemicals to rush into the graft site, seeking to fight infection. Unfortunately, those same processes cause inflammation and scarring, which in turn cause implanted tendon to stick to the joint. To work properly, the tendon must be free to glide across the joint. Tendon adhesions, a longstanding post-surgical problem, cause pain and permanently limit range of motion.

86. 594 GENE THERAPY
    Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.  
    http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1365-2516.2002.00025.x

87. The Scientist : Gene Therapy Trial On Hold
    As the US Food and Drug Administration prepares to investigate the death of a patient in a phase I/II gene therapy trial for inflammatory arthritis,  
    http://www.the-scientist.com/news/home/53453/
    
    Extractions: By Chandra Shekhar NEWS [Published 31st July 2007 04:57 PM GMT] As the US Food and Drug Administration prepares to investigate the death of a patient in a phase I/II gene therapy trial for inflammatory arthritis, researchers in the field say the treatment's delivery vector, an adeno-associated virus (AAV), was unlikely to be the culprit. "Vectors in this class have been used on hundreds of patients over the last 12 years, and are not associated with acute toxicity," said Terence Flotte of the University of Massachusetts Medical School in Worcester. Flotte has been a principal investigator in several clinical trials of AAV-based gene therapy, but is not associated with the trial in question. "I've never seen anything like this," he told The Scientist . "Whatever this is, it's unusual."

88. Child Gets Leukaemia After Gene Therapy | Science | The Guardian
    A threeyear-old boy has developed leukaemia as a result of gene therapy, Great Ormond Street children s hospital in London said yesterday.  
    http://www.guardian.co.uk/science/2007/dec/19/cancer.medicalresearch
    
    Extractions: Close This article appeared in the Guardian on Wednesday December 19 2007 on p14 of the UK news section. It was last updated at 14:46 on January 15 2008. A three-year-old boy has developed leukaemia as a result of gene therapy, Great Ormond Street children's hospital in London said yesterday. The boy, who was born without an immune system, was given gene therapy as a baby to save his life.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

81-88 of 88    Back | 1  | 2  | 3  | 4  | 5